Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PHI-101 |
Synonyms | |
Therapy Description |
PHI-101 is a Chk2 inhibitor with additional activity against FLT3, which potentially results in antitumor activity (Cancer Res 2021;81(13_Suppl):Abstract nr 1461, Cancer Res 2020;80(16 Suppl):Abstract nr 4226). |